Nyheter
Big Biotech in the Bargain Bin
Big Biotech in the Bargain Bin The sell-off in biotech stocks that began last summer has resulted in valuations that are on par with and in some cases lower than those seen in the broad equity market (at this writing, 2/17/16). Biotech valuations have not dipped this low since the aftermath of the 2007-2008 financial crisis. For investors with an appetite for biotech, this may provide a bargain-priced opportunity.
Since 2005 U.S. biotech stocks have traded at higher earnings multiples than the broader S&P 500® Index. Over the last 10 years biotech stocks have had an average price-earnings (P/E) ratio of 23.3 versus 16.2 for the S&P 500 Index. Today those metrics are nearly equivalent in the 16 P/E range. A number of large-cap biotech companies have traded below general market valuations, e.g., Amgen (AMGN), which traded at 16.2x earnings and Gilead Sciences (GILD) at 7.7x earnings, as of 2/17/16. By comparison, Market Vectors® Biotech ETF (BBH) has a P/E ratio of 18.6 as of 2/17/16. BBH seeks to track the Market Vectors U.S. Listed Biotech 25 Index, which is comprised of the 25 largest and most liquid U.S.-listed biotech stocks.
P/Es of Biotech Stocks Fall Below P/E of Broader U.S. Equities
Historical Averages 12/31/2005 – 2/17/2016
(Click to enlarge) Past performance is no guarantee of future results. Index performance is not illustrative of fund performance.
While pricing concerns, weakness in emerging markets currencies, and the strength of the U.S. dollar may have contributed to weakness in biotech, there may be better news down the road. The expected total number of upcoming clinical trials, new drug applications, and new biologics up for approval is 32% higher now than five years ago.1 As the global population ages, demand for drugs is growing. Additionally, the current price environment may compel large biotech companies with healthy cash balances to grow their businesses through acquisitions or engage in share buyback programs; such activity could support share prices.
Amidst these trends, investors may consider targeting large biotech companies via an exchange-traded fund such as Market Vectors Biotech ETF ( BBH) to potentially capture value in the biotech industry.
Sources: VanEck, FactSet and Bloomberg. Data as of 2/17/2016.
ETFs is authored by VanEck thought leaders. VanEck is the sponsor of Market Vectors ETFs and is currently among the largest providers of exchange traded funds (ETFs) in the U.S. and worldwide. Market Vectors ETFs empower investors to help build better portfolios with access to compelling investment themes and strategies. Our ETFs span many global asset classes, and are built to be transparent, liquid, and pure-play reflections of target markets.
Authored by Gabor Gurbacs, ETF Data Analyst
IMPORTANT DISCLOSURE
1 Source: Bloomberg and VanEck ETF Research
Index Descriptions: (i) The S&P 500 (The Standard & Poor’s 500) Index is an American stock market index based on the market capitalizations of 500 large companies having common stock listed on the NYSE or NASDAQ. (ii) The S&P 500 Biotechnology Index represent the biotechnology sub-industry segment of the S&P 500 Index. (iii) The Market Vectors® US Listed Biotech 25 Index comprises of the 25 largest and most liquid U.S. listed biotech companies.
Price/Earnings Ratio is the price of a security divided by the earnings per share of the security.
AK8G ETF köper tyska statsobligationer med förfall 2027
FLXS ETF är ett sätt att få exponering mot Saudiarabien
HODL fyller sex år
BT27 ETF köper italienska statsobligationer med förfall 2027
WisdomTree lanserar Physical XRP ETP
Börshandlade fonder med månatlig utdelning
Vilka börshandlade fonder lockade mest i oktober 2024?
Post-election recap: Three takeaways for crypto investors
JEQP ETF spårar Nasdaq-100 och ger en månadsvis utdelning
JEIP ETF spårar amerikanska aktier och ger en månadsvis utdelning
-
Nyheter3 veckor sedanBörshandlade fonder med månatlig utdelning
-
Nyheter3 veckor sedanVilka börshandlade fonder lockade mest i oktober 2024?
-
Nyheter1 vecka sedanPost-election recap: Three takeaways for crypto investors
-
Nyheter2 veckor sedanJEQP ETF spårar Nasdaq-100 och ger en månadsvis utdelning
-
Nyheter2 veckor sedanJEIP ETF spårar amerikanska aktier och ger en månadsvis utdelning
-
Nyheter2 veckor sedanNya ETFer från J.P. Morgan ger tillgång till amerikanska företag i kombination med en överlagringsstrategi
-
Nyheter3 veckor sedanKryptokorgar: Automatisk diversifiering av kryptoinvesteringar
-
Nyheter2 veckor sedanJ.P. Morgan Asset Management utökar sitt Equity Premium Income Active UCITS ETF-sortiment och listar JEPI och JEPQ i Europa
